Company: G
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001140361-25-013031
Chunk: 76

Company: Genpact LTD
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 76
---
 See “Narrative disclosure to summary compensation table and grants of plan-based awards table—Employment agreements with named executive officers” above for a description of these provisions. Incentive compensation plans The treatment of outstanding equity awards granted to our named executive officers in 2024 in the event of certain terminations of employment and/or a change of control is described above under “Narrative disclosure to summary compensation table and grants of plan-based awards table—“Restricted share unit awards” and “Performance share unit awards.” The treatment of outstanding equity awards granted to our named executive officers in 2023 in the event of certain terminations of employment is the same as with respect to the 2024 grants. The treatment of outstanding equity awards granted to our NEOs prior to 2023 in the event of certain terminations of employment is generally the same as with respect to the 2023 and 2024 grants, except that (a) the equity awards granted prior to 2023 do not include any acceleration in the event of termination due to retirement, (b) in the event of a named executive officer’s termination by reason of death or disability, the 2022 PSU awards vest on a pro-rated basis based on actual performance, while the 2023 and 2024 PSU awards vest on a pro-rated basis based on target performance, and (c) RSU awards granted to our named executive officers prior to 2023 do not include any acceleration in the event of a named executive officer’s termination by reason of death or disability.

| 59 | 2025 Proxy Statement |

TABLE OF CONTENTS

| |EXECUTIVE OFFICER COMPENSATION |

Termination and change of control potential payments and benefits table The amounts disclosed in the table below are based on the payments and benefit costs that would have been incurred by the Company if the named executive officer’s employment had terminated as of the last business day of the fiscal year ended December 31, 2024. The amounts included below do not include payments and benefits to the extent they are provided on a non-discriminatory basis to salaried employees generally upon termination of employment. Where applicable, the value of one of our common shares on December 31, 2024 was $42.95, which was the closing market price of our common shares on the NYSE on such date.

|                       |     |               |     |                   |     |               |     |             |     |               |     | Change of control(2) |     |